The purpose of this study is to evaluate and compare the efficiency of healthcare systems among 28 countries around the world by applying the data envelopment analysis (DEA) method. Two output variables are used: life expectancy at birth and infant mortality rate. Four input variables are used:...

The EU approved the first biosimilar drug in 2006. By 2017, the EU had authorized the highest number of biosimilars worldwide, acquiring considerable experience in their use and safety. In May 2019, the European Medicines Agency (EMA) search engine showed 54 authorized biosimilars. Biosimilars...

Background: The use of research evidence to inform policy and practice cannot be overemphasized especially in low and middle-income countries (LMICs). To promote the use of research evidence in the provision of health services for enhanced effective control of communicable diseases in developing...

Local government units (LGU) are nowadays facing the very difficult and complicated task of making reasonable decisions regarding the transforming of SPZOZs into capital companies. First, it seems necessary to carry out a simulation of costs and advantages of the assumed models and solutions...

The purpose of this study is to evaluate and compare the efficiency of healthcare systems among 28 countries around the world by applying the data envelopment analysis (DEA) method. Two output variables are used: life expectancy at birth and infant mortality rate. Four input variables are used:...